Dr. Allison Brashear's lab at the University at Buffalo focuses on studying the genetic mutations of the ATP1A3 gene, which can cause a variety of neurological disorders. By employing a mix of patient phenotyping and laboratory testing, the lab aims to understand the symptoms related to these mutations and find potential treatments. They explore how these mutations affect cellular functions and how existing drugs can be used to alleviate symptoms, ultimately hoping to broaden diagnosis and treatment options for affected individuals.

Dr. Marc W Halterman's lab focuses on the connection between the lungs and the brain during acute ischemic stroke. They study how lung injuries can affect inflammation and recovery after a stroke, aiming to discover new treatments that target lung issues to help improve brain outcomes. The research may lead to innovative therapies that could help mitigate complications related to strokes and other neurological conditions.